Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Boyle

Showing results (121-130 of 184) with videos related to

Pageof 19
Sort By:
BJU International|February 23, 2007
The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studiesChris Robertson, Carol L Link, Erol Onel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2016
The State of Lung Cancer Research: A Global AnalysisAjay Aggarwal, Grant Lewison, Saliha Idir, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|May 22, 2012
Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphomaQian Deng, Tongzhang Zheng, Qing Lan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 2012
Genetic polymorphisms in oxidative stress pathway genes and modification of BMI and risk of non-Hodgkin lymphomaChristopher Kim, Tongzhang Zheng, Qing Lan, et al.
Cancer Causes & Control : CCC|August 5, 2009
Menstrual and reproductive factors and pancreatic cancer in the SEARCH program of the IARCEric J Duell, Patrick Maisonneuve, Peter A Baghurst, et al.
American Journal of Epidemiology|December 6, 2008
Occupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut womenRong Wang, Yawei Zhang, Qing Lan, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 23, 2002
[Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study]Frans Debruyne, Gary Koch, Peter Boyle, et al.
Cancer Causes & Control : CCC|October 25, 2003
Alcohol use and risk of non-Hodgkin's lymphoma among Connecticut women (United States)Lindsay McOmber Morton, Theodore R Holford, Brian Leaderer, et al.
European Urology|June 21, 2002
Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international studyFrans Debruyne, Gary Koch, Peter Boyle, et al.
BJU International|March 7, 2008
Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortalityGeorg Bartsch, Wolfgang Horninger, Helmut Klocker, et al.
Pageof 19

Showing results (121-130 of 184) with videos related to

Sort By:
Pageof 19
BJU International|February 23, 2007
The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studiesChris Robertson, Carol L Link, Erol Onel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2016
The State of Lung Cancer Research: A Global AnalysisAjay Aggarwal, Grant Lewison, Saliha Idir, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|May 22, 2012
Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphomaQian Deng, Tongzhang Zheng, Qing Lan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 2012
Genetic polymorphisms in oxidative stress pathway genes and modification of BMI and risk of non-Hodgkin lymphomaChristopher Kim, Tongzhang Zheng, Qing Lan, et al.
Cancer Causes & Control : CCC|August 5, 2009
Menstrual and reproductive factors and pancreatic cancer in the SEARCH program of the IARCEric J Duell, Patrick Maisonneuve, Peter A Baghurst, et al.
American Journal of Epidemiology|December 6, 2008
Occupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut womenRong Wang, Yawei Zhang, Qing Lan, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 23, 2002
[Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study]Frans Debruyne, Gary Koch, Peter Boyle, et al.
Cancer Causes & Control : CCC|October 25, 2003
Alcohol use and risk of non-Hodgkin's lymphoma among Connecticut women (United States)Lindsay McOmber Morton, Theodore R Holford, Brian Leaderer, et al.
European Urology|June 21, 2002
Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international studyFrans Debruyne, Gary Koch, Peter Boyle, et al.
BJU International|March 7, 2008
Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortalityGeorg Bartsch, Wolfgang Horninger, Helmut Klocker, et al.
Pageof 19